A Study of MK-0616 (Oral PCSK9 Inhibitor) in Adults With Hypercholesterolemia (MK-0616-013) CORALreef Lipids
Hypercholesterolemia, Familial Hypercholesterolemia
About this trial
This is an interventional treatment trial for Hypercholesterolemia
Eligibility Criteria
Inclusion Criteria: Has a history of a major atherosclerotic cardiovascular disease (ASCVD) event and LDL-C ≥55 mg/dL OR, if no history of a major ASCVD event, has intermediate to high risk for development of a first major ASCVD event and LDL-C ≥70 mg/dL Is treated with a moderate- or high-intensity statin OR is treated with low-intensity statin with documentation of intolerance to a moderate or high-intensity statin OR is not receiving statins with documentation of statin intolerance If on any lipid-lowering therapies (LLTs), should be on a stable dose with no planned medication change Exclusion Criteria: Has a history of homozygous familial hypercholesterolemia (FH) based on genetic or clinical criteria, compound heterozygous FH, or double heterozygous FH Has a history of heart failure or heart failure hospitalization within 3 months before first study visit Is undergoing or previously underwent an LDL-C apheresis program within 3 months before first study visit or plans to initiate an LDL-C apheresis program Was previously treated/is being treated with certain other cholesterol lowering medications, including protein convertase subtilisin/kexin type 9 (PCSK9) inhibitors without adequate washout
Sites / Locations
- Alliance for Multispecialty Research, LLC ( Site 0093)Recruiting
- G&L Research ( Site 0043)Recruiting
- Synexus Clinical Research US, Inc.-Synexus Clinical Research US, Inc - Central Phoenix ( Site 0084)Recruiting
- Velocity Clinical Research, Banning ( Site 0017)Recruiting
- National Heart Institute-Research ( Site 0087)Recruiting
- Clinical Trials Research ( Site 0115)Recruiting
- Emerson Clinical Research Institute ( Site 0118)Recruiting
- Excel Medical Clinical Trials ( Site 0053)Recruiting
- Alliance for Multispecialty Research, LLC ( Site 0088)Recruiting
- Alliance for Multispecialty Research, LLC ( Site 0094)Recruiting
- Velocity Clinical Research, Hallandale Beach ( Site 0018)Recruiting
- Jacksonville Center for Clinical Research ( Site 0049)Recruiting
- South Broward Research ( Site 0051)Recruiting
- Clinical Research Trials of Florida ( Site 0063)Recruiting
- East Coast Institute for Research, LLC ( Site 0033)Recruiting
- Healthcare Research Network - Chicago ( Site 0052)Recruiting
- Synexus Clinical Research US - Evansville ( Site 0109)Recruiting
- Midwest Institute For Clinical Research ( Site 0059)Recruiting
- Alliance for Multispecialty Research, LLC ( Site 0028)Recruiting
- L-MARC Research Center ( Site 0001)Recruiting
- Velocity Clinical Research, Slidell ( Site 0068)Recruiting
- Meridian Clinical Research, LLC ( Site 0082)Recruiting
- Velocity Clinical Research, Gulfport ( Site 0039)Recruiting
- Healthcare Research Network - St. Louis ( Site 0054)Recruiting
- Jubilee Clinical Research ( Site 0106)Recruiting
- AB Clinical Trials ( Site 0070)Recruiting
- New Mexico Clinical Research & Osteoporosis Center ( Site 0005)Recruiting
- Velocity Clinical Research, Syracuse ( Site 0021)Recruiting
- Icahn School of Medicine at Mount Sinai-Cardiology ( Site 0002)Recruiting
- Lillestol Research ( Site 0026)Recruiting
- altoona center for clinical research ( Site 0089)Recruiting
- Cardiology Consultants of Philadelphia Yardley ( Site 0097)Recruiting
- Piedmont Research Partners ( Site 0090)Recruiting
- Velocity Clinical Research, Greenville ( Site 0023)Recruiting
- Coastal Carolina Research Center ( Site 0006)Recruiting
- Holston Medical Group ( Site 0048)Recruiting
- Alliance for Multispecialty Research, LLC ( Site 0008)Recruiting
- Velocity Clinical Research, Dallas ( Site 0114)Recruiting
- Center for Cardiometabolic Disease Prevention/Baylor College of Medicine ( Site 0111)Recruiting
- Clinical Trials of Texas, LLC ( Site 0103)Recruiting
- Synexus Clinical Research US, Inc. ( Site 0110)Recruiting
- Velocity Clinical Research, Salt Lake City ( Site 0019)Recruiting
- Manassas Clinical Research Center ( Site 0007)Recruiting
- Health Research of Hampton Roads, Inc. ( Site 0044)Recruiting
- Alliance for Multispecialty Research, LLC ( Site 0101)Recruiting
- National Clinical Research, Inc ( Site 0061)Recruiting
- Centricity Research Suffolk Primary Care ( Site 0092)Recruiting
- Rainier Clinical Research Center ( Site 0116)Recruiting
- CEDIC ( Site 0612)Recruiting
- Centro de Investigaciones Metabólicas (CINME)-Cardiology ( Site 0620)Recruiting
- Instituto de Investigaciones Clínicas Mar del Plata ( Site 0605)Recruiting
- Centro Medico Dra. Laura Maffei- Investigacion Clinica Aplicada ( Site 0604)Recruiting
- Fundación Respirar ( Site 0610)Recruiting
- Rambam Health Care Campus-internal department ( Site 1718)Recruiting
- Hadassah Medical Center ( Site 1709)Recruiting
- Sheba Medical Center ( Site 1708)Recruiting
- Yitzhak Shamir Medical Center ( Site 1712)Recruiting
- Hirohata Naika Clinic ( Site 3513)Recruiting
- Nakakinen clinic ( Site 3510)Recruiting
- Noritake Clinic ( Site 3512)Recruiting
- National Hospital Organization Kanazawa Medical Center ( Site 3508)Recruiting
- Hirano Medical Clinic ( Site 3522)Recruiting
- Shirai Healthcare Clinic Izumichuou ( Site 3527)Recruiting
- Rinku General Medical Center ( Site 3503)Recruiting
- Shiraiwa Medical Clinic ( Site 3514)Recruiting
- Medical Corporation Heishinkai OCROM Clinic ( Site 3501)Recruiting
- Saitama Medical University Hospital ( Site 3506)Recruiting
- Teramoto Medical and Dental Clinic ( Site 3507)Recruiting
- Tokyo-Eki Center-building Clinic ( Site 3505)Recruiting
- Fukuwa Clinic ( Site 3504)Recruiting
- Kato Clinic of Internal Medicine ( Site 3509)Recruiting
- Kanno Naika ( Site 3511)Recruiting
- Sugawara Clinic ( Site 3519)Recruiting
- Shin Clinic - Tokyo - Nishikamata ( Site 3517)Recruiting
- Heishinkai Medical Group ToCROM Clinic ( Site 3502)Recruiting
- Mitsukoshi Health and Welfare Foundation ( Site 3521)Recruiting
- Medical Corporation Hakuaikai Wellness Tenjin Clinic ( Site 3520)Recruiting
- Mishuku Hospital ( Site 3524)Recruiting
- Chungbuk National University Hospital ( Site 3011)Recruiting
- Wonju Severance Christian Hospital ( Site 3008)Recruiting
- Chonnam National University Hospital ( Site 3014)Recruiting
- Seoul National University Bundang Hospital ( Site 3005)Recruiting
- Ajou University Hospital ( Site 3006)Recruiting
- Dong-A University Hospital ( Site 3013)Recruiting
- Pusan National University Hospital-Internal Medicine ( Site 3012)Recruiting
- Inje University Haeundae Paik Hospital ( Site 3010)Recruiting
- Keimyung University Dongsan Hospital ( Site 3003)Recruiting
- Seoul National University Hospital ( Site 3001)Recruiting
- Kangbuk Samsung Hospital ( Site 3009)Recruiting
- Severance Hospital, Yonsei University Health System ( Site 3002)Recruiting
- Asan Medical Center ( Site 3004)Recruiting
- Samsung Medical Center-cardiology ( Site 3000)Recruiting
- The Catholic Univ. of Korea Seoul St. Mary's Hospital-cardiology ( Site 3007)Recruiting
- Changhua Christian Hospital ( Site 3101)Recruiting
- National Taiwan University Hospital ( Site 3100)Recruiting
- Taipei Medical University Hospital-Cardiology ( Site 3108)Recruiting
- Taipei Veterans General Hospital ( Site 3106)Recruiting
- Hacettepe Universite Hastaneleri ( Site 2500)Recruiting
- Ankara Bilkent Şehir Hastanesi-cardiology ( Site 2501)Recruiting
- Eskisehir Osmangazi University-Cardiology ( Site 2510)Recruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Placebo Comparator
MK-0616
Placebo
Participants will receive 20 mg of MK-0616 orally once daily (QD) for up to 52 weeks.
Participants will receive MK-0616-matching placebo orally QD for up to 52 weeks.